Incorporation of the antitumor alkaloid thaliblastine in liposomes enhances its cytotoxic activity in vitro.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001060:Aporphines / Q000008:administration & dosage / Q000494:pharmacology*; D002279:Carcinoma 256, Walker / Q000473:pathology; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D008081:Liposomes; D008223:Lymphoma / Q000473:pathology; D051379:Mice; D008808:Mice, Inbred CBA; D051381:Rats; D011919:Rats, Inbred Strains
D000970:Antineoplastic Agents; D001060:Aporphines; D008081:Liposomes